Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules
暂无分享,去创建一个
J. Pawlotsky | C. Sautès-Fridman | F. Petitprez | W. Fridman | J. Calderaro | L. Lacroix | A. Bougoüin | M. Roncalli | D. Sommacale | G. Amaddeo | A. Laurent | L. di Tommaso | M. Meylan | Fouad Lafdil | C. Charpy | J. Derman | H. Regnault
[1] S. Friedman,et al. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents. , 2019, Gastroenterology.
[2] M. Ziol,et al. Molecular and histological correlations in liver cancer. , 2019, Journal of hepatology.
[3] C. Sautès-Fridman,et al. Tertiary lymphoid structures in the era of cancer immunotherapy , 2019, Nature Reviews Cancer.
[4] A. Luciani,et al. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. , 2019, Journal of hepatology.
[5] Y. Abe,et al. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification , 2018, Hepatology.
[6] M. Roncalli,et al. Phenotypic and molecular changes in nodule‐in‐nodule hepatocellular carcinoma with pathogenetic implications , 2018, Histopathology.
[7] A. Luciani,et al. Macrotrabecular‐massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance , 2018, Hepatology.
[8] R. Stupp,et al. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer , 2017, Oncoimmunology.
[9] Holger Moch,et al. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. , 2018, Cancer research.
[10] Rohit Loomba,et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity , 2017, Nature.
[11] S. Imbeaud,et al. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. , 2017, Journal of hepatology.
[12] M. Esteller,et al. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. , 2017, Gastroenterology.
[13] A. Luciani,et al. Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features , 2016, Hepatology.
[14] E. Galun. Liver inflammation and cancer: The role of tissue microenvironment in generating the tumor‐promoting niche (TPN) in the development of hepatocellular carcinoma , 2016, Hepatology.
[15] T. Ichikawa,et al. Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications. , 2016, Journal of hepatology.
[16] K. Rajewsky,et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma , 2015, Nature Immunology.
[17] J. Zucman‐Rossi,et al. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis , 2014, Hepatology.
[18] M. Karin,et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. , 2014, Cancer cell.
[19] Kristen Jepsen,et al. Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling , 2013, Cell.
[20] V. Sondak,et al. 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy? , 2012, Scientific Reports.
[21] T. Yeatman,et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. , 2011, The American journal of pathology.
[22] M. Karin,et al. NF-κB and STAT3 – key players in liver inflammation and cancer , 2011, Cell Research.
[23] M. Kurrer,et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. , 2009, Cancer cell.
[24] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[25] Michiie Sakamoto,et al. Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.
[26] L. Terracciano,et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis , 2007, Hepatology.
[27] Y. Ben-Neriah,et al. NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.
[28] Rinat Abramovitch,et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.
[29] G. Freeman,et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.
[30] T. Takahara,et al. Functional B‐cell response in intrahepatic lymphoid follicles in chronic hepatitis C , 1999, Hepatology.
[31] 村上 純. Functional B cell response in intrahepatic lymphoid follicles in chronic hepatitis C , 1999 .
[32] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.